Rolipram had no effect on Aβ peptide levels or plaque load in the PS/APP and Tg2576 strains [20, 21], although treatment over 24 days was shown to decrease Aβ peptide levels in brain tissue from 11-month-old 3xTg-AD mice [22]. This evidence concerns the gene APP and Alzheimer disease.